Hubungan Kadar Asam Urat, Laktat Dehidrogenase, Aspartat Aminotransferase Serum Penderita Preeklamsi Berat Disertai Komplikasi dan tanpa Komplikasi
Abstract
Tujuan: penelitian ini untuk mencari perbedaan kadar asam urat, laktat dehydrogenase (LDH) dan aspartat aminotransferase (AST) pada serum penderita preeklamsi berat disertai komplikasi dan tanpa komplikasi dan mengukur kuatnya hubungan peningkatan kadar asam urat, LDH dan AST dengan peningkatan risiko terjadinya komplikasi pada pasien preeklamsi berat.
Metode: Rancangan penelitian ini adalah penelitian comparative cross sectional dengan metode consecutive sampling. Subjek penelitian adalah penderita preeklamsi berat disertai komplikasi dan tanpa komplikasi (n=68).
Hasil: Hasil penelitian didapatkan perbedaan kadar asam urat, LDH dan AST pada kedua kelompok secara bermakna dengan nilai p ≤ 0,05. Peningkatan kadar asam urat, LDH dan AST berhubungan dengan peningkatan risiko terjadinya komplikasi dengan nilai cut off kadar asam urat > 6,5 mg/dL sebesar 33 kali, LDH > 573 U/L sebesar 8,95 kali dan AST > 30 U/L sebesar 5,19 kali. Jika terjadi peningkatan seluruh kadar asam urat, LDH dan AST diatas nilai cut off maka risiko terjadinya komplikasi sebesar 98,1%.
Kesimpulan: Penelitian ini menyimpulkan kadar asam urat, LDH, AST pada preeklamsi berat disertai komplikasi lebih tinggi dibandingkan preeklamsi berat tanpa komplikasi dan peningkatan kadar asam urat, LDH, AST berhubungan dengan peningkatan risiko terjadinya komplikasi pada preeklamsi berat.
Relations of Uric Acid, Lactat Dehydrogenase, and Aspartat Aminotransferase Serum LevelIn Severe Preeclampsia with and Without Complications
Abstract
Objective: This study compared level of uric acid, LDH, and AST level between severe preeclampsia patients with complication and without complication, and measured correlation between the rise level of uric acid, LDH and AST towards the increased risk of complication in patient with severe preeclampsia.
Method: The study design was comparative cross sectional study with consecutive sampling method that compare the results of laboratorium uric acid, LDH, AST between complications and without complications group. Subjects of this study were severe preeclampsia patients with and without complication that fulfilled study criteria (n=68). Result: It is revealed that the differences level of uric acid, LDH, and AST in both groups were significant with p value ≤ 0.05. Increase level of uric acid, LDH, and AST were related to inreased risk of complication in severe preeclampsia occurence with cut off point of uric acid level of > 6.5 mg/dL by 33 times, LDH level of > 573 U/L by 8.95 times, and AST level of > 30 U/L by 5.19 times. If all uric acid, LDH, and AST level rise above the cut off value so the risk of complication of severe preeclampsia will rise by 98.1%.
Conclusion: It is concluded that level of uric acid, LDH, and AST in severe preeclampsia with complication were higher than severe preeclampsia without complication and the rise of uric acid, LDH, and AST were related with the rise of complication risk on severe preeclampsia.
Key word: Severe preeclampsia, complication, uric acid, LDH, AST
Keywords
Full Text:
PDFReferences
Hidayat D. Epidemiologi. In: Sabarudin U, Pribadi A, Pramatirta AY, editors. Preeklamsi. 1 ed. Bandung: Dep./SMF Obstetri & Ginekologi Fakultas Kedokteran Universitas Padjadjaran RSUP DR. Hasan Sadikin 2015. p. 3-9.
Cunningham FG, Leveno KJ, Bloom SL, Spong CY, Dashe JS, Hoffman BL, et al. Williams Obstetrics. 24 ed. New York: The McGraw-Hill Companies; 2014.
Laporan Tahunan 2015. Bandung: SMF Departemen Obstetri dan Ginekologi/FK Unpad RSUP DR. Hasan Sadikin; 2015. p. 41-2.
Krisnadi S. Penatalaksanaan Komplikasi Preeklamsi. In: Sabarudin U, Pribadi A, Pramatirta AY, editors. Preeklamsi. Bandung: Dep./SMF Obstetri & Ginekologi Fakultas Kedokteran Universitas Padjadjaran RSUP DR. Hasan Sadikin 2015. p. 49-59.
Martin JN, Jr., May WL, Magann EF, Terrone DA, Rinehart BK, Blake PG. Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity. Am J Obstet Gynecol. 1999;180(6 Pt 1):1407-14.
Bainbridge SA, Roberts JM. Uric acid as a pathogenic factor in preeclampsia. Placenta. 2008;29:67-72.
Johnson RJ, Kang D-H, Feig D, Kivlighn S, Kanellis J, Watanabe S, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003;41(6):1183-90.
Parrish M, Griffin M, Morris R, Darby M, Owens MY, Martin Jr JN. Hyperuricemia facilitates the prediction of maternal and perinatal adverse outcome in patients with severe/superimposed preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine. 2010;23(12):1451-5.
Andrews L, Patel N. Correlation of serum lactate dehydrogenase and pregnancy induced hypertension with its adverse outcomes. International Journal of Research in Medical Sciences. 2016;4(5):1347-50.
Panteghini M, Solinge WWv. Enzymes. In: Burtis CA, Ashwood ER, bruns DE, editors. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 1. 4 ed. Missouri: Elsevier Saunders; 2006. p. 597-643.
Umasatyasri Y, Van I, Shamita P. Role of LDH (Lactate dehydrogenase) in preeclampsia eclampsia as a prognostic marker: An observational study. 2015.
Thangaratinam S, Koopmans CM, Iyengar S, Zamora J, Ismail KM, Mol BW, et al. Accuracy of liver function tests for predicting adverse maternal and fetal outcomes in women with preeclampsia: a systematic review. Acta obstetricia et gynecologica Scandinavica. 2011;90(6):574-85.
Demir C, Evruke C, Ozgunen FT, Urunsak IF, Candan E, Kadayifci O. Factors that influence morbidity and mortality in severe preeclampsia, eclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome. Saudi medical journal. 2006;27(7):1015-8.
DOI: http://dx.doi.org/10.24198/obgynia.v3i1.195
Refbacks
- There are currently no refbacks.
_CROSREF22.jpg)
